Continuous glucose monitoring is continuing to expand beyond its traditional role in diabetes care. On Wednesday, Silicon Valley-based startup Signos raised $20 million for its glucose monitoring ...

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...

Teladoc Health announced Wednesday that it is launching two new AI-powered capabilities built into its Solo smart care ...

Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor ...

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...

Walgreens launched a new digital weight management offering on Thursday, which provides access to clinician-led support and GLP-1s. The program is available to adults ages 18 to 64 who are overweight ...

Fraud, waste, and abuse (FWA) continue to challenge dental plans as overtreatment, miscoding and inappropriate billing ...

Nobody has ever needed convincing on what to fix. What they've lacked is a way to act on it themselves, in something close to ...

The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...

Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re ...

Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi ...

AI could play a meaningful role in advancing social care. Not by replacing people, but by helping them and organizations ...